Granite Point Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Granite Point Capital Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-30,000	Closed	-$577K	–	103
2019 Q3	$577K	Sell	30,000 -1,800	-6%	-$41.2K	0.09%	56
2019 Q2	$940K	Buy	31,800 +13,200	+71%	+$509K	0.06%	65
2019 Q1	$884K	Hold	18,600	–	–	0.09%	69
2018 Q4	$671K	Hold	18,600	–	–	0.14%	63
2018 Q3	$1.15M	Hold	18,600	–	–	0.08%	76
2018 Q2	$1.26M	Sell	18,600 -6,400	-26%	-$358K	0.11%	66
2018 Q1	$1.36M	Sell	25,000 -21,000	-46%	-$1.17M	0.13%	49
2017 Q4	$2.75M	Sell	46,000 -3,800	-8%	-$230K	0.27%	20
2017 Q3	$2.42M	Sell	49,800 -12,159	-20%	-$663K	0.51%	23
2017 Q2	$3.26M	Sell	61,959 -23,000	-27%	-$1.07M	0.8%	18
2017 Q1	$3.85M	Sell	84,959 -49,541	-37%	-$2.21M	1.15%	13
2016 Q4	$5.09M	Hold	134,500	–	–	4.06%	4
2016 Q3	$5.08M	Buy	134,500 +78,275	+139%	+$1.73M	1.98%	10
2016 Q2	$990K	Buy	+56,225	New	+$910K	0.42%	43
2015 Q4	$3.29M	Buy	135,000 +65,000	+93%	+$1.52M	0.49%	10
2015 Q3	$1.24M	Buy	+70,000	New	+$1.27M	0.85%	29

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Granite Point Capital Management's AERI Position: Q4 2019 in Review

Granite Point Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2019, closing a stake of 30,000 shares — an estimated $577K sold.

Granite Point Capital Management first reported a position in AERI in Q3 2015 and held it in 16 quarters. The position peaked at $5.09M in Q4 2016. 167 funds tracked by Wall St. Rank hold AERI as of Q4 2019.

Granite Point Capital Management reported no remaining Aerie Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Granite Point Capital Management sold 30,000 Aerie Pharmaceuticals shares in Q4 2019, an estimated $577K.
Granite Point Capital Management first reported a position in Aerie Pharmaceuticals in Q3 2015 and held it in 16 quarters.
Granite Point Capital Management's Aerie Pharmaceuticals position peaked at $5.09M in Q4 2016.
167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2019.

Based on Granite Point Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.